Source:http://linkedlifedata.com/resource/pubmed/id/19275662
General Info
Affiliation
Department of Nuclear Medicine, Affiliated Hospital, Luzhou Medical College, Luzhou, Sichuan, China.Abstract
Imaging of glucose metabolism has resulted in significant improvements in staging and follow-up in oncology. (18)F-FDG PET has become a routine clinical test for most solid tumours. Several radionuclide-labeled derivatives of deoxyglucose that have shown that glucose metabolic imaging may be a useful tool for improving tumour staging, restaging, and monitoring of tumour response to therapy.
PMID
19275662
Publication types
Research Support, Non-U.S. Gov't